Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Monarch Private Capital Celebrates the Preservation and Reopening of the Historic Louis Sullivan Building in Newark, Ohio
-
SEALSQ to Kick Off Quantum Partnership with BWT Alpine Formula One Team on November 19-21 at Las Vegas Grand Prix
-
GigaCloud Technology Inc Recognized in TIME’s ‘America’s Growth Leaders 2026’ List
-
ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results
-
Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the Second Fiscal Quarter and Declaration of Distributions on Common Stock for the Months Ending January, Februar
-
Conner Strong & Buckelew Announces First-of-Its-Kind Insurance Program for Cell & Gene Therapy Product Shortages
-
Satellogic Appoints Industry Veteran Jeff Kerridge to Lead Global Sales and Drive Next Phase of Growth
-
NEXGEL to Report Third Quarter 2025 Financial Results on November 11th
-
Avalyn to Participate in Multiple Upcoming Investor Conferences in November
-
Recludix Pharma to Present at Two Investor Conferences in November
-
Septerna to Participate in Upcoming Investor Conferences
-
Nuvini Outlines Long-Term Operating Targets Highlighting Scalable SaaS Model
-
Elicio Therapeutics to Present Clinical and Preclinical Data at the SITC 2025 Annual Meeting
-
Esperion to Participate in Jefferies Global Healthcare Conference - London
-
ASML reports transactions under its current share buyback program
-
Ardena strengthens executive leadership with appointments of Chief Quality Officer and Chief Information Officer
-
STMicroelectronics announces status of common share repurchase program
-
Orchestra BioMed to Host Business Update Call on November 12, 2025
-
Teva Kicks Off ‘The Other TD’ to Raise Awareness of Tardive Dyskinesia (TD), with Support from Pro Football Hall of Famer Terrell Davis
-
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Globo Comunicação e Participações S.A. Announces Launch of Cash Tender Offers
-
iFLYTEK AINOTE 2 Set to Sell Globally on November 1, 2025, Redefining Professional Productivity with Advanced AI
-
Ramsey Theory Group CEO Dan Herbatschek Publishes Five Key ROI Metrics for Enterprise AI and Reveals the One Critical Mistake
-
Stellar Pictures Brings High-Profile IPs to Cannes & London, Showcasing Chinese Culture
-
Stellar Pictures Brings High-Profile IPs to Cannes & London, Showcasing Chinese Culture
-
Luvme Hair Announces 2025 Black Friday Wigs Sale and Saving Guide
-
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.08 Per Share for November 2025
-
ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
-
ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
-
MDC Releases Commentary: Digital Wallet Oversight—What New U.S. Payment App Rules Mean for Casino Transactions
-
First American Uranium Inc. Announces Change of Stock Symbol and Uplisting to the OTCQB Venture Market
-
QGold Commences Trading on OTCQB® under QGLDF on the Venture Market
-
L.B. Foster Announces Continuing Sales Growth and Robust Cash Generation in Fiscal Third Quarter with Expected Strong Finish to 2025
-
Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
-
Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder
-
Kalaris Expands Leadership Team Appointing Matthew Gall, MBA, as Chief Financial Officer
-
Kailera Therapeutics Appoints Frank Clyburn to Board of Directors
-
Apogee Therapeutics to Participate in Upcoming Conferences
-
DeFi Crypto Mutuum Finance (MUTM) Details V1 Launch Roadmap as Phase 6 Nears 90% Allocation
-
NIP Group Expands Bitcoin Mining Capacity with Additional Asset-Purchase Agreement
-
Genie Energy Announces Third Quarter 2025 Results
-
Digi Power X Strengthens Balance Sheet to Support 2026 AI Infrastructure Development Plan
-
Dyne Therapeutics to Present at Upcoming Investor Conferences
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025
-
Osisko Development Strengthens Technical Team With Appointment of Vice President, Exploration
-
Phoenix Asia Holdings Limited Announces Addition to Board of Directors
-
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
-
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025
-
InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer
